Tenaya to present TN-401 gene therapy data at ASGCT 2026 meeting

April 27, 2026 8:30 AM

Tenaya Therapeutics Inc. (NASDAQ: TNYA) will present new clinical data from its RIDGE-1 Phase 1b/2 trial of TN-401 gene therapy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found